[{"source":"FTC USA Business Blog Posts","id":3191275,"description":"Lights out on unsubstantiated pain relief claims and deceptive native advertising lfair June 25, 2020 | 3:00PM Lights out on unsubstantiated pain relief claims and deceptive native advertising By Lesley Fair For consumers struggling with severe or chronic pain, ads for a product called Willow Curve appeared to offer light at the end of the tunnel. But the FTC alleges the marketers made false and unsubstantiated claims for the product , a device that applied low-level light and mild heat to the site of pain – and set people back between $599 and $799 in the process. The proposed settlement also sheds light on the FTC’s ongoing concern with deceptive native advertising. The complaint names two Michigan companies, Physician’s Technology, LLC, and Willow Labs, LLC, and two individuals affiliated with both businesses, Dr. Ronald Shapiro and David Sutton. In ads on national TV, satellite radio, online, and in social media, the defendants claimed that for people suffering from rheumatoid arthritis, diabetic neuropathy, nerve damage, shingles, fibromyalgia, lupus, torn tendons, and other serious conditions, the light-emitting Willow Curve would provide “real, lasting, proven pain relief, without the costs, risks or inconvenience associated with elective surgery, prescription drugs or office visits.” The defendants also sold Willow Curve through a network of distributors and resellers, supplying them with promotional materials touting the product’s purported health benefits. What’s more, the defendants claimed to have clinical studies to support what they said about Willow Curve and that the FDA had reviewed and approved the device for its advertised pain relief and other health benefits. The FTC challenges those claims as false. The complaint also alleges the defendants advertised a “risk-free” and “money-back” guarantee for consumers if they were “not completely satisfied” within a specified time period. But the FTC says in many instances, the defendants required consumers to jump through hoops to get the hefty purchase price back – for example, by first undertaking a regimen of 92 “treatments” over a 180-day period. According to the complaint, those requirements were hidden behind hyperlinks or buried in paperwork in the Willow Curve box. Despite the defendants’ claim that they issued refunds within seven to ten business days, the FTC says some people never got their money back. Others got a refund a year or more later or only after reporting the defendants to a State Attorney General or the Better Business Bureau. Another notable count relates to the defendants’ use of native advertising. For example, what appeared to be an online magazine article, “Understanding the Gender Gap in Sports Injuries and Treatment,” was actually advertising for Willow Curve. According to the FTC, the defendants hired a marketing company to write this article and others, which looked a lot like the non-advertising content of the magazines and newspapers in which the ads ran. The complaint alleges the articles weren’t identifiable as ads, including when consumers posted or shared them on social media or in email. The settlement includes a judgment of $22 million, which – based on the defendants’ financial condition – will be partially suspended when defendants Shapiro and Sutton each pay $200,000. Among other things, the proposed order requires the defendants to have randomized, double-blind, and placebo-controlled testing to support a broad range of pain relief claims. The order also prohibits them from representing expressly or by implication that advertising is a statement or opinion from an independent publisher or source. The case illuminates some issues of interest to advertisers. Support pain relief claims with sound science.   There’s a predictable cycle. As more consumers experience chronic and serious pain, more marketers position their products as purported remedies. What comes next?","pubDate":"Thu, 01 Oct 2026 14:10:47 +0200","titre":"Lights out on unsubstantiated pain relief claims and deceptive native advertising","url":"https://www.ftc.gov/business-guidance/blog/2020/06/lights-out-unsubstantiated-pain-relief-claims-deceptive-native-advertising"},{"pubDate":"Fri, 06 Feb 2026 09:48:14 +0100","url":"https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-sending-nearly-23-million-consumers-who-invested-deceptive-sanctuary-belize-kanantik-real-estate","titre":"FTC is Sending Nearly $23 Million to Consumers Who Invested in the Deceptive Sanctuary Belize and Kanantik Real Estate Development Schemes","source":"Federal Trade Commission - Protecting America's Consumers","id":2679350,"description":"The Federal Trade Commission is returning nearly $23 million to consumers nationwide who bought deceptively marketed overseas real estate lots in what the sellers pitched as Sanctuary Belize, a supposed luxury development in southern, coastal Belize, as well as its nearby sister development, Kanantik. The FTC is mailing 1,659 checks to defrauded investors. The average amount of each check for Sanctuary Belize consumers is $16,462 and the average amount of each check for Kanantik consumers is $6,346.39. Today’s announcement represents the second mailing to consumers who invested in the Sanctuary Belize scheme, with approximately  $10 million distributed previously . The first round of checks was sent only to consumers who bought property within Sanctuary Belize. Today’s checks are going to both Sanctuary Belize investors, as well as consumers who invested in Kanantik, a related development owned and operated by some of the Sanctuary Belize defendants, and other areas covered by the court relief in this case. In November 2018, the FTC filed a complaint charging that Andris Pukke, a prior FTC defendant, and several other corporate and individual defendants deceived consumers who invested in Sanctuary Belize by promising they were investing in a luxury development and resort. The defendants, however, failed to deliver on the promised amenities, and consumers who invested in Sanctuary property lost money and could not resell their lots. Following a trial in 2020, a federal court found that the defendants, who took in more than $100 million, duped consumers into buying Sanctuary Belize lots by falsely claiming it would be a safe investment, that the development would include luxury amenities and be completed soon, and that consumers could resell their lots. The defendants appealed,  but the Court of Appeals confirmed the deceptive scheme and the monetary judgment against Pukke and his associates, Peter Baker and John Usher. The District Court  ordered the receiver to send an initial round of payments , with the money coming from previous settlements. As part of a second round of payments, the Commission is sending a total of $22,865,008.34 to consumers. Checks totaling $20,028,170.25 are being sent to 1,202 claim applicants who invested in properties within Sanctuary Belize, and checks totaling $2,836,838.09 are being sent to 447 claim applicants who invested in properties in the Kanantik and other covered development areas. Consumers who receive checks in this second distribution should cash them within 60 days, as indicated on the check. Consumers with questions about their payments should email the redress administrator, Rust Consulting, which is being supported by Ankura Consulting Group, LLC, at Payment@SanctuaryBelizeRedress.com . Consumers with other questions about the Sanctuary Belize receivership can contact  info@sanctuarybelizereceivership.com . The application process for requesting a payment is closed, and the receiver is no longer accepting applications from consumers. Consumers can also visit the receivership website at  www.SanctuaryBelizeReceivership.com to find other resources such as"}]